Floatz logo

Tolvaptan

Cirrhosis Of Liver

Institute of Liver and Biliary Sciences, IndiaSmall moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
78/ 100
Competitive Position
73/ 100

Competitive context

133 Active assets in the Cirrhosis Of Liver cohort.

Asset / SponsorPhaseRating
Veruprevir
AbbVie
Phase 3A
Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-Nh2 (4-9 Disulfide)
General Hospital of Shenyang Military Region
Phase 4BBB
NORMAL HUMAN SERUM ALBUMIN
King George's Medical University
Phase 4BBB
Ribavirin
Peking University People's Hospital
Phase 4BBB
CHOLYL-LYSL-FLUORESCEIN
Norgine
Phase 3BBB

View all 50 →

Same molecule, other indications

Tolvaptan is also rated in:

inappropriate ADH syndromeActive
BBB
Indicative · Phase 3
74 / 100
View asset →
water intoxicationDormant
BB
Indicative · Phase 3
68 / 100
View asset →
mineral metabolism diseaseDormant
BB
Indicative · Phase 3
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →